Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab
Study Identifier
P16-346
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
19 - 99 Years
Protocol Summary
The objective of this non-interventional, observational study is to assess the effect of adalimumab on health-related quality of life in participants with Psoriasis in Korea.
Study Locations
Location
Status
Location
Hallym University Sacred Heart Hospital /ID# 161697
Anyang-si, Gyeonggi-do, Gyeonggido, Republic of Korea, 14068
Status
Not applicable
Location
CHA Bundang Medical center, CHA University /ID# 161696
Seongnam-si, Gyeonggido, Republic of Korea, 13496
Status
Not applicable
Location
Ajou University Hospital /ID# 161698
Suwon, Gyeonggido, Republic of Korea, 16499
Status
Not applicable
Location
Yonsei University Health System, Severance Hospital /ID# 166300
Seodaemun-gu, Seoul Teugbyeolsi, Republic of Korea, 03722
Status
Not applicable
Location
Hanyang University Seoul Hospi /ID# 169553
Seongdong-gu, Seoul Teugbyeolsi, Republic of Korea, 04763
Status
Not applicable
Location
Busan National University Hosp /ID# 166299
Busan, Republic of Korea, 602-739
Status
Not applicable
Showing {first} - {last} of {total} Results